A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
NCT01531842 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2012-02-13
Summary
This is a research study to evaluate the effects of repeated intravitreal injections on bacteria around the eye.
Conditions
- Central Retinal Vein Occlusion
- Choroidal Neovascularization
- Age-related Macular Degeneration
- Branch Retinal Vein Occlusion
Interventions
- PROCEDURE
-
Conj flora Antibiotic resistance
Patients will either receive a drop of topical antibiotic before and after the intravitral injection or no topical antibiotics (only typical prep with betadine).
Sponsors & Collaborators
-
Mid Atlantic Retina
lead OTHER
Principal Investigators
-
Jason Hsu, MD · Mid Atlantic Retina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
NCT00349739 ·Status: NO_LONGER_AVAILABLE
-
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
NCT02321839 ·Status: COMPLETED ·Phase: PHASE4
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration
NCT01780935 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
NCT00058994 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion
NCT01011374 ·Status: UNKNOWN ·Phase: PHASE1
-
Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)
NCT00636493 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
NCT05662943 ·Status: COMPLETED
-
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213 ·Status: COMPLETED
-
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
NCT00855608 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
NCT00395551 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
NCT00056836 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
NCT01256632 ·Status: COMPLETED ·Phase: NA
-
A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy
NCT00809419 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
NCT00695682 ·Status: UNKNOWN ·Phase: PHASE1
-
Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora
NCT01577342 ·Status: COMPLETED ·Phase: NA
-
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
NCT02484690 ·Status: COMPLETED ·Phase: PHASE2
-
Conbercept in Choroidal Neovascularization Secondary to Uveitis
NCT02934841 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration
NCT01926977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Photodynamic and Pharmacologic Treatment of CNV
NCT00570193 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration
NCT02060604 ·Status: COMPLETED ·Phase: PHASE4
-
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
NCT00304954 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV
NCT01809223 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
NCT02510794 ·Status: COMPLETED ·Phase: PHASE2